US Stock MarketDetailed Quotes

TPST Tempest Therapeutics

Watchlist

0.966
+0.108+12.52%

Trading Jan 3 13:29 ET

42.15MMarket Cap-0.63P/E (TTM)

Tempest Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Total revenue

Operating revenue

--0

Cost of revenue

Gross profit

Operating expense

60.06%10.55M

28.27%9.58M

5.18%7.97M

-15.83%29.16M

-15.89%7.51M

-24.84%6.59M

-14.86%7.47M

-7.11%7.58M

28.36%34.64M

21.75%8.93M

Selling and administrative expenses

26.28%2.99M

22.63%3.75M

25.18%3.63M

-3.75%11.66M

6.08%3.33M

-15.26%2.37M

-2.21%3.05M

-4.88%2.9M

23.35%12.11M

19.71%3.14M

-General and administrative expense

26.28%2.99M

22.63%3.75M

25.18%3.63M

-3.75%11.66M

6.08%3.33M

-15.26%2.37M

-2.21%3.05M

-4.88%2.9M

23.35%12.11M

19.71%3.14M

Research and development costs

79.03%7.56M

32.18%5.84M

-7.23%4.34M

-22.32%17.5M

-27.80%4.18M

-29.33%4.22M

-21.85%4.42M

-8.44%4.68M

31.23%22.53M

22.88%5.79M

Operating profit

-60.06%-10.55M

-28.27%-9.58M

-5.18%-7.97M

15.83%-29.16M

15.89%-7.51M

24.84%-6.59M

14.86%-7.47M

7.11%-7.58M

-28.36%-34.64M

-21.75%-8.93M

Net non-operating interest income expense

97.42%-5K

110.81%12K

227.27%70K

65.72%-349K

109.32%11K

-10.23%-194K

71.83%-111K

83.33%-55K

20.16%-1.02M

70.50%-118K

Non-operating interest income

81.01%324K

57.38%384K

51.56%438K

83.33%1.1M

23.57%388K

-15.96%179K

248.57%244K

9,533.33%289K

8,471.43%600K

606.45%314K

Non-operating interest expense

-11.80%329K

4.79%372K

6.98%368K

-10.44%1.45M

-12.73%377K

-4.11%373K

-23.49%355K

3.30%344K

26.21%1.62M

27.81%432K

Other net income (expense)

129.41%15K

-24.39%-51K

Other non- operating income (expenses)

----

129.41%15K

----

-24.39%-51K

----

Income before tax

-55.56%-10.56M

-26.24%-9.57M

-3.51%-7.9M

17.41%-29.49M

17.74%-7.49M

24.15%-6.79M

17.31%-7.58M

10.07%-7.64M

-26.17%-35.71M

-17.02%-9.1M

Income tax

Net income

-55.56%-10.56M

-26.24%-9.57M

-3.51%-7.9M

17.41%-29.49M

17.74%-7.49M

24.15%-6.79M

17.31%-7.58M

10.07%-7.64M

-26.17%-35.71M

-17.02%-9.1M

Net income continuous Operations

-55.56%-10.56M

-26.24%-9.57M

-3.51%-7.9M

17.41%-29.49M

17.74%-7.49M

24.15%-6.79M

17.31%-7.58M

10.07%-7.64M

-26.17%-35.71M

-17.02%-9.1M

Minority interest income

Net income attributable to the parent company

-55.56%-10.56M

-26.24%-9.57M

-3.51%-7.9M

17.41%-29.49M

17.74%-7.49M

24.15%-6.79M

17.31%-7.58M

10.07%-7.64M

-26.17%-35.71M

-17.02%-9.1M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-55.56%-10.56M

-26.24%-9.57M

-3.51%-7.9M

17.41%-29.49M

17.74%-7.49M

24.15%-6.79M

17.31%-7.58M

10.07%-7.64M

-26.17%-35.71M

-17.02%-9.1M

Basic earnings per share

14.58%-0.41

22.22%-0.42

34.55%-0.36

38.19%-1.91

46.03%-0.34

27.27%-0.48

31.65%-0.54

53.39%-0.55

58.63%-3.09

44.04%-0.63

Diluted earnings per share

14.58%-0.41

22.22%-0.42

34.55%-0.36

38.19%-1.91

46.03%-0.34

27.27%-0.48

31.65%-0.54

53.39%-0.55

58.63%-3.09

44.04%-0.63

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Total revenue	0	0	0	0	0	0	0	0	0	0
Operating revenue	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Cost of revenue
Gross profit
Operating expense	60.06%10.55M	28.27%9.58M	5.18%7.97M	-15.83%29.16M	-15.89%7.51M	-24.84%6.59M	-14.86%7.47M	-7.11%7.58M	28.36%34.64M	21.75%8.93M
Selling and administrative expenses	26.28%2.99M	22.63%3.75M	25.18%3.63M	-3.75%11.66M	6.08%3.33M	-15.26%2.37M	-2.21%3.05M	-4.88%2.9M	23.35%12.11M	19.71%3.14M
-General and administrative expense	26.28%2.99M	22.63%3.75M	25.18%3.63M	-3.75%11.66M	6.08%3.33M	-15.26%2.37M	-2.21%3.05M	-4.88%2.9M	23.35%12.11M	19.71%3.14M
Research and development costs	79.03%7.56M	32.18%5.84M	-7.23%4.34M	-22.32%17.5M	-27.80%4.18M	-29.33%4.22M	-21.85%4.42M	-8.44%4.68M	31.23%22.53M	22.88%5.79M
Operating profit	-60.06%-10.55M	-28.27%-9.58M	-5.18%-7.97M	15.83%-29.16M	15.89%-7.51M	24.84%-6.59M	14.86%-7.47M	7.11%-7.58M	-28.36%-34.64M	-21.75%-8.93M
Net non-operating interest income expense	97.42%-5K	110.81%12K	227.27%70K	65.72%-349K	109.32%11K	-10.23%-194K	71.83%-111K	83.33%-55K	20.16%-1.02M	70.50%-118K
Non-operating interest income	81.01%324K	57.38%384K	51.56%438K	83.33%1.1M	23.57%388K	-15.96%179K	248.57%244K	9,533.33%289K	8,471.43%600K	606.45%314K
Non-operating interest expense	-11.80%329K	4.79%372K	6.98%368K	-10.44%1.45M	-12.73%377K	-4.11%373K	-23.49%355K	3.30%344K	26.21%1.62M	27.81%432K
Other net income (expense)				129.41%15K					-24.39%-51K
Other non- operating income (expenses)	----	----	----	129.41%15K	----	----	----	----	-24.39%-51K	----
Income before tax	-55.56%-10.56M	-26.24%-9.57M	-3.51%-7.9M	17.41%-29.49M	17.74%-7.49M	24.15%-6.79M	17.31%-7.58M	10.07%-7.64M	-26.17%-35.71M	-17.02%-9.1M
Income tax	0	0	0	0	0	0	0	0	0	0
Net income	-55.56%-10.56M	-26.24%-9.57M	-3.51%-7.9M	17.41%-29.49M	17.74%-7.49M	24.15%-6.79M	17.31%-7.58M	10.07%-7.64M	-26.17%-35.71M	-17.02%-9.1M
Net income continuous Operations	-55.56%-10.56M	-26.24%-9.57M	-3.51%-7.9M	17.41%-29.49M	17.74%-7.49M	24.15%-6.79M	17.31%-7.58M	10.07%-7.64M	-26.17%-35.71M	-17.02%-9.1M
Minority interest income
Net income attributable to the parent company	-55.56%-10.56M	-26.24%-9.57M	-3.51%-7.9M	17.41%-29.49M	17.74%-7.49M	24.15%-6.79M	17.31%-7.58M	10.07%-7.64M	-26.17%-35.71M	-17.02%-9.1M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-55.56%-10.56M	-26.24%-9.57M	-3.51%-7.9M	17.41%-29.49M	17.74%-7.49M	24.15%-6.79M	17.31%-7.58M	10.07%-7.64M	-26.17%-35.71M	-17.02%-9.1M
Basic earnings per share	14.58%-0.41	22.22%-0.42	34.55%-0.36	38.19%-1.91	46.03%-0.34	27.27%-0.48	31.65%-0.54	53.39%-0.55	58.63%-3.09	44.04%-0.63
Diluted earnings per share	14.58%-0.41	22.22%-0.42	34.55%-0.36	38.19%-1.91	46.03%-0.34	27.27%-0.48	31.65%-0.54	53.39%-0.55	58.63%-3.09	44.04%-0.63
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--

Heat List

Overall

No Data